Phase I Trial of Trastuzumab Deruxtecan in Combination with Neratinib in Solid Tumors with HER2 Alterations (NCI 10495)
CANCER RESEARCH(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined